![Bill L. Nichols](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
William L.
Nichols is President at Protagenic Therapeutics, Inc. since 2026.
Mr. Nichols was Head-US Sales at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Bill L. Nichols active positions
| Companies | Position | Start |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | President | 03/02/2026 |
Former positions of Bill L. Nichols
| Companies | Position | End |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Sales & Marketing | 01/01/2019 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
- Stock Market
- Insiders
- Bill L. Nichols
